Physician profile
James S Distefano
NPI 1457324782
$499.35
in general payments reported to CMS, 2019-2025
10 companies · $35.74 in 2025
The $35.74 reported for 2025 was less than what a typical Sports Medicine (Emergency Medicine) provider received nationally (typical 2025 total: $100).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $54.79 · 2021: $107 · 2022: $33.59 · 2024: $138 · 2025: $35.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $105.03 | 2021-2024 | Xiaflex |
| Janssen Biotech, INC. | $102.03 | 2024 | Stelara, Tremfya |
| Evolution Surgical, INC | $99.59 | 2019 | |
| Bioventus LLC | $69.03 | 2019-2022 | |
| Depuy Synthes Sales INC. | $32.59 | 2019-2020 | |
| Smith+Nephew, INC. | $24.11 | 2020 | |
| Endo USA, INC. | $21.98 | 2025 | Xiaflex |
| Takeda Pharmaceuticals U.S.A., INC. | $20.16 | 2024 | Gattex |
| Stryker Corporation | $13.76 | 2025 | Na |
| Horizon Therapeutics Plc | $11.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Distefano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.